Treating Co-Occurring Opioid Use Disorder in Mental Health Settings-View Presentation Slides

View Presentation Slides

Pdf Summary

The document is a presentation by the American Psychiatric Association discussing the treatment of co-occurring opioid use disorder (OUD) within mental health settings. The presentation aims to equip participants with knowledge on screening and diagnostic tools for OUD, the feasibility of using FDA-approved medications in mental health settings, and the integration of these medications into mental health programs.<br /><br />Dr. Brian Hurley, a medical director specializing in substance abuse prevention, presents the material, which outlines the commonality of co-occurring disorders in mental health, highlighting the need for integrated treatment approaches. Key statistics reveal that approximately 50% of individuals with substance use disorders have a co-occurring mental illness, with depression, anxiety, and bipolar disorder being the most prevalent among those with OUD.<br /><br />The webinar details the use of various medications like methadone, buprenorphine, and naltrexone as part of Medication for Opioid Use Disorder (MOUD) which have shown to effectively reduce overdose deaths and increase treatment retention. Despite these benefits, only a small proportion of individuals with co-occurring disorders receive adequate treatment due to factors like stigma, lack of training, and logistical barriers.<br /><br />The document also emphasizes the importance of continuous and accessible pharmacotherapy without obligatory concurrent psychosocial support, as outlined in the "Medication First Model." Challenges such as navigating multiple service providers and long waiting lists for specialty care are also discussed.<br /><br />Screening tools including TAPS and ASSIST for drug use, as well as criteria for diagnosing substance use disorders per DSM-5 guidelines, are presented. Psychotherapeutic approaches and their role alongside pharmacotherapy are mentioned, underscoring the comprehensive care model required for treating OUD in individuals with mental health disorders. <br /><br />To claim continuing education credits, participants must follow the outlined procedure upon conclusion of the webinar.

Keywords

Opioid Use Disorder

Mental Health

Integrated Treatment

Medication for OUD

Co-occurring Disorders

Brian Hurley

Screening Tools

Medication First Model

Pharmacotherapy

DSM-5